KDM5B and melanoma: In this regard, it has been demonstrated that slow-cycling melanoma cells intrinsically resistant to PLX4032, to many chemotherapeutic drugs and to radiotherapy, overexpressed KDM5B, the histone H3KA demethylase which contribute to maintain OXPHOS and to enhance GSH-related processes (57–60).